The investigators goal is to conduct a pilot randomized controlled trial (RCT) whose purpose is to determine the feasibility of a randomized trial designed to determine if either inhaled beclomethasone or a combination of inhaled beclomethasone/salbutamol (Clenil Compositum) are superior to placebo in treating pre-school aged children with an acute wheezing episode.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Alberta Children's Hospital
Calgary, Alberta, Canada
Reduce unplanned-symptomatic visits to clinicians
Time frame: After enrolment is complete
Reduce the number of days with respiratory symptoms
Time frame: Will be analyzed 1-2 months after enrolment is complete, looking at the full follow-up period of 21 days
Reduce the need for rescue salbutamol use
Time frame: Will be analyzed 1-2 months after enrolment is complete, looking at the full follow-up period of 21 days
Reduce hospitalization rates of target population
Time frame: Will be analyzed 1-2 months after enrolment is complete, looking at the full follow-up period of 21 days
Reduce overall societal health care costs of target population
Time frame: Will be analyzed 1-2 months after enrolment is complete, looking at the full follow-up period of 21 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.